Search
- Feb 28
5AM Ventures' Andy Schwab shares his take on biotech cycles and key themes of today
Andy Schwab describes founding 5AM in 2002 and discusses portfolio companies Radionetics, Latigo, TMRW, and Skye Bioscience.
Also look for unique social pages for BiotechTV U.
#1. Ultragenyx's Emil Kakkis on Angelman syndrome data, rare disease treatment modalities, and more
#2. The CEO of Madrigal on the launch of Rezdiffra for NASH liver disease
#3. Sutro Biopharma's CEO on ADCs, non-cell protein synthesis, and more
#4. Verve Therapeutics' CEO on today's gene editing clinical trial pause
#5. Daphne Zohar on becoming the CEO of Seaport Therapeutics and a $100M series A